Precision-Guided Movement Training
Robots deliver consistent, controlled motion patterns that promote motor learning and support neural reorganisation.



Rymo's robotic rehabilitation systems facilitate repetitive, precise, and personalised training that supports activity-dependent neuroplasticity across a range of neurological conditions

Robotic rehabilitation devices are a key innovation in modern neuro therapy. By delivering controlled, repeatable therapeutic movements, robotic systems help therapists provide high-dose, task-specific training that is challenging to sustain through manual therapy alone. Evidence supports intensive, task-oriented practice as a primary driver of neuromotor recovery and robotic technology enables consistent delivery of this dose.


¹ *Repetition figures are illustrative estimates based on published literature in upper limb stroke rehabilitation. Actual values vary by condition, session duration, device mode, and patient capacity.*
Robotic therapy complementing traditional therapy combining high-dose repetitive practice via robotics with therapist expertise in functional training, manual techniques, and patient education.
Robots deliver consistent, controlled motion patterns that promote motor learning and support neural reorganisation.
Supports the high dosage and repetition required for neuroplasticity and motor recovery.
Real-time measurements support data-informed clinical decisions and personalised therapy adjustments.
Interactive gamification and VR improve motivation and compliance during therapy sessions.
Evidence-informed high-dose, task-specific training for functional recovery.
Interactive gaming transforming challenging therapy into engaging activities.
Session data is shared with your therapist to guide and adjust your plan.
Comprehensive Solutions Across the Neurorehabilitation Continuum


*All rehabilitation using Rymo devices should be prescribed and supervised by a licensed physiotherapist. Goals and expected outcomes vary by condition, severity, and individual patient factors, and are determined in partnership with the treating clinical team.*